Adolfo Ramirez-Zamora, MD

Adolfo Ramirez-Zamora, MD

Adolfo Ramirez-Zamora, MD

Associate Professor, Neurology
Director of Clinical Trials, UF Health Center for Movement Disorders and Neurorestoration

Dr. Adolfo Ramirez-Zamora is currently an Associate Professor of Neurology and director of clinical trials at the University of Florida, Center for Movement Disorders and Neurorestoration which is part of the Center for Translational Research in Neurodegenerative Diseases and the McKnight Brain Institute. Dr. Ramirez practiced neurology over the past 5 years at the Parkinson’s Disease and Movement Disorders Center at Albany Medical Center where he served as an Associated Professor of Neurology and the Philly E. Dake Chair in Movement Disorders. Dr. Ramirez completed a surgical internship at Mercy hospital of Philadelphia along with a medicine internship At Bassett Healthcare Hospital in Cooperstown, NY. He then went on to complete his neurology residency at Loyola University Chicago followed by fellowship training in movement disorders at the University of California San Francisco. Dr. Ramirez’s unique areas of expertise encompass management of the entire spectrum of movement disorders, cerebellar ataxias and the use of botulinum toxin injections and Deep Brain Stimulation (DBS) for the treatment of movement disorders.

His research interests include investigating new DBS surgical and programming techniques in movement disorders, understanding the neurophysiological brain changes observed in these conditions and the use of neuromodulation for the treatment of uncommon neurological diseases. Dr. Ramirez has a strong interest and experience in conducting clinical trials in Neurology. His clinical focus comprises evaluation of experimental therapeutics in neurology with interested in developing newer treatments in movement disorders.  He serves as a member of the Diversity leadership program and Science Committee at the American Academy of Neurology (AAN) and he is an active member of the Ataxia foundation, Movement Disorders Society, Parkinson Study Group, and Huntington Study Group.